Pharmaceutical

Adcendo raises $135m as ADC funding frenzy continues 

This latest raise is intended to accelerate the development of the biotech’s four antibody-drug conjugates.

Nov 27, 2024 - 06:00
Adcendo raises $135m as ADC funding frenzy continues 
This latest raise is intended to accelerate the development of the biotech’s four antibody-drug conjugates.
Read the original article

Tags:

Previous Article

Pharmaceutical Technology Excellence Awards 2024: PCI Pharma Services 

Next Article

Sustainability in biopharma: Collaboration and technology light the way forward

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Call for earlier diagnosis to improve Gaucher disease outcomes

Call for earlier diagnosis to improve Gaucher disease o...

Jan 19, 2024

STAT+: Pharmalittle: Appeals court rules Purdue can shield Sacklers from lawsuits; chemo shortage blamed on drugmakers’ lack of investment

STAT+: Pharmalittle: Appeals court rules Purdue can shi...

May 31, 2023

FDA issues draft guidance on stimulant use disorder drug development

FDA issues draft guidance on stimulant use disorder dru...

Oct 5, 2023